Previous 10 | Next 10 |
Cancer Genetics (CGIX) -18%.Obalon Therapeutics (OBLN) -17%.Adamis Pharmaceuticals (ADMP) -17%.Marathon Patent Group (MARA) -11% as Bitcoin crumbles despite good news rolls in.Riot Blockchain (RIOT) -11% as Bitcoin crumbles despite good news rolls in.Foresight Autonomous (...
Aptorum Group Limited (NASDAQ: APM) receives clearance from the Public Health Agency of Canada in regards to its Clinical Trial Application to begin Phase 1 study of ALS-4, its orally taken small molecule drug that is intended to treat infections that are caused by Staphylococ...
Caladrius Biosciences (CLBS) +120%.Aptorum Group (APM) +61% as Canada approves early-stage infection drug trial.Steel Connect (STCN) +54%.Dare Bioscience (DARE) +39%.ENDRA Life Sciences (NDRA) +36%.Lineage Cell Therapeutics (LCTX) +34%.Inuvo (INUV) +33%.eMagin Corporation (EMAN) +28...
Small-cap Aptorum (APM) soars 65% in premarket after Health Canada signs off its trial application to commence a Phase 1 study of the company's lead candidate, ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus includi...
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, announced that the company, through its wholly owned subsidiar...
Gainers: [[VOXX]] +42.9%. [[IRIX]] +22.0%. [[PXLW]] +11.8%. [[QTRX]] +7.9%. [[GNMK]] +6.9%.Losers: [[RDHL]] -9.4%. [[LINC]] -6.1%. [[LMND]] -5.3%. [[APM]] -3.9%. [[REVG]] -3.6%. For further details see: VOXX, IRIX, RDHL and LINC among after-hours movers
Aptorum Group (APM) has submitted a Clinical Trial Application with the regulatory authority of Canada, to commence a Phase 1 study evaluating ALS-4 for the treatment of infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus. The 80-subject study...
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies for the treatment of a variety of medical conditions including infectious diseases, announc...
Regulatory News: Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the “Company”, “Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announce...
Universal Security Instruments (UUU) +87%.Cellect Biotechnology (APOP) +36%.Pinterest (PINS) +31% on Q3 results.Inphi Corporation (IPHI) +27% as the company will be acquired by Marvell in a cash and stock transaction.Xtant Medical Holdings (XTNT) +22% on Q3 resul...
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - July 17, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) will report its second quarter 2024 financial and operating results after market close on Tuesday, August 13, 2024. Management will host a conference call...
Toronto, Ontario--(Newsfile Corp. - July 16, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) announced that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprieta...
Toronto, Ontario--(Newsfile Corp. - July 11, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) is pleased to announce the appointment of Sylvain Lessard as President and General Manager of Golden Queen Mine, effective today, July 11, 2024. Wi...